Lorena Lima, Elaine Alves, Bianca Santos, Adriana Assumpção, Priscila Oliveira, Priscilla Monteiro, Julia Mascarenhas, Clara Rizzo, Sérgio Morgado, Luiz Mascarenhas
{"title":"Active surveillance cultures for multidrug-resistant Gram-negative organisms in the intensive care unit: is it necessary to conduct them weekly?","authors":"Lorena Lima, Elaine Alves, Bianca Santos, Adriana Assumpção, Priscila Oliveira, Priscilla Monteiro, Julia Mascarenhas, Clara Rizzo, Sérgio Morgado, Luiz Mascarenhas","doi":"10.3205/dgkh000645","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Multidrug-resistant Gram-negative bacteria (MDR-GNB) pose a major threat to public health due to the limited treatment options and their frequent association with healthcare-associated infections. Active surveillance culture (ASC), a component of infection prevention strategies, remains controversial. This study evaluated the effectiveness of ASC performed weekly versus only upon ICU admission and discharge for detecting MDR-GNB.</p><p><strong>Materials and methods: </strong>In a prospective study, two monitoring strategies were compared over a period of 18 months in six intensive care units. Phase 1 involved conducting ASC weekly, while Phase 2 entailed conducting ASC exclusively at the time of ICU admission and discharge.</p><p><strong>Results: </strong>A total of 233 MDR-GNB infections were documented: 130 (11.38/1,000 patient-days) in Phase 1 and 103 (8.47/1,000 patient-days) in Phase 2. This reflects a statistically significant decrease in infection rates in Phase 2 (IRR: 1.34; 95% CI: 1.04-1.74). No significant differences were observed in species-specific infection rates between the two phases.</p><p><strong>Conclusions: </strong>Reducing ASC frequency from weekly to only ICU admission and discharge did not increase MDR-GNB infection rates. The implementation of comprehensive infection prevention and control measures proved sufficient for the management of bacterial infections.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"21 ","pages":"Doc36"},"PeriodicalIF":1.6000,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13103860/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS Hygiene and Infection Control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/dgkh000645","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: Multidrug-resistant Gram-negative bacteria (MDR-GNB) pose a major threat to public health due to the limited treatment options and their frequent association with healthcare-associated infections. Active surveillance culture (ASC), a component of infection prevention strategies, remains controversial. This study evaluated the effectiveness of ASC performed weekly versus only upon ICU admission and discharge for detecting MDR-GNB.
Materials and methods: In a prospective study, two monitoring strategies were compared over a period of 18 months in six intensive care units. Phase 1 involved conducting ASC weekly, while Phase 2 entailed conducting ASC exclusively at the time of ICU admission and discharge.
Results: A total of 233 MDR-GNB infections were documented: 130 (11.38/1,000 patient-days) in Phase 1 and 103 (8.47/1,000 patient-days) in Phase 2. This reflects a statistically significant decrease in infection rates in Phase 2 (IRR: 1.34; 95% CI: 1.04-1.74). No significant differences were observed in species-specific infection rates between the two phases.
Conclusions: Reducing ASC frequency from weekly to only ICU admission and discharge did not increase MDR-GNB infection rates. The implementation of comprehensive infection prevention and control measures proved sufficient for the management of bacterial infections.